Five Critical Challenges in Investigator Site Selection and How Clinical Data Science Can Solve Them
Poor investigator site selection remains a significant driver of spiraling costs and inefficiencies in clinical development.
Gen Li, PhD, MBA
Advertisement
Articles by Gen Li, PhD, MBA
A discussion of the cost and time put into clinical trials.
Advertisement
Latest Updated Articles
Clinical Trials Don't Have to Cost Too Much or Take Too LongPublished: May 8th 2018 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
Novo Nordisk’s Stock Reacts to Unsuccessful Phase III Trial Results
2
What Does the List of Approved Drugs Reveal About FDA's Priority Review Voucher Program?
3
Eye Care and Earned Media: What Makes Pharma Stories Newsworthy
4
Moderna Takes Out $1.5 Billion Loan as Part of Three-Year Business Plan
5
